Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Form 8.3

12th Feb 2026 15:47

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

(a) Full name of discloser	Qube Research & Technologies Limited
(b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree	Avadel Pharmaceuticals plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)
(e) Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure	11/02/2026
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”	YES / NO / N/A If YES, specify which: Please fill in manually

2. INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security (Note 3)	$0.01 ordinary shares
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled	3,288,219.00	3.37
(2) Cash-settled derivatives
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell
Total	3,288,219.00	3.37

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant	Purchase/sale	Number of	Price per unit
security	Purchase/sale	securities	(Note 5)
USD 0.01 ordinary shares	Purchase	1170576	21.64
USD 0.01 ordinary shares	Purchase	700	21.645
USD 0.01 ordinary shares	Purchase	40091	21.65
USD 0.01 ordinary shares	Purchase	600	21.653
USD 0.01 ordinary shares	Purchase	29192	21.655
USD 0.01 ordinary shares	Purchase	100	21.658
USD 0.01 ordinary shares	Purchase	89750	21.66
USD 0.01 ordinary shares	Purchase	704	21.662
USD 0.01 ordinary shares	Purchase	78	21.662
USD 0.01 ordinary shares	Purchase	267	21.662
USD 0.01 ordinary shares	Purchase	341	21.662
USD 0.01 ordinary shares	Purchase	1300	21.663
USD 0.01 ordinary shares	Purchase	37	21.663
USD 0.01 ordinary shares	Purchase	1138	21.663
USD 0.01 ordinary shares	Purchase	972	21.664
USD 0.01 ordinary shares	Purchase	264	21.664
USD 0.01 ordinary shares	Purchase	602	21.664
USD 0.01 ordinary shares	Purchase	496	21.664
USD 0.01 ordinary shares	Purchase	78	21.665
USD 0.01 ordinary shares	Purchase	47962	21.665
USD 0.01 ordinary shares	Purchase	187	21.667
USD 0.01 ordinary shares	Purchase	285	21.667
USD 0.01 ordinary shares	Purchase	380	21.667
USD 0.01 ordinary shares	Purchase	194	21.667
USD 0.01 ordinary shares	Purchase	50111	21.67
USD 0.01 ordinary shares	Purchase	78	21.671
USD 0.01 ordinary shares	Purchase	82	21.672
USD 0.01 ordinary shares	Purchase	202	21.672
USD 0.01 ordinary shares	Purchase	17	21.672
USD 0.01 ordinary shares	Purchase	665	21.672
USD 0.01 ordinary shares	Purchase	2000	21.673
USD 0.01 ordinary shares	Purchase	127	21.673
USD 0.01 ordinary shares	Purchase	142	21.674
USD 0.01 ordinary shares	Purchase	55	21.674
USD 0.01 ordinary shares	Purchase	2239	21.675
USD 0.01 ordinary shares	Purchase	61627	21.675
USD 0.01 ordinary shares	Purchase	141	21.675
USD 0.01 ordinary shares	Purchase	116	21.676
USD 0.01 ordinary shares	Purchase	171	21.676
USD 0.01 ordinary shares	Purchase	231	21.677
USD 0.01 ordinary shares	Purchase	1108	21.677
USD 0.01 ordinary shares	Purchase	136	21.677
USD 0.01 ordinary shares	Purchase	124	21.677
USD 0.01 ordinary shares	Purchase	84	21.677
USD 0.01 ordinary shares	Purchase	391	21.677
USD 0.01 ordinary shares	Purchase	73	21.677
USD 0.01 ordinary shares	Purchase	43	21.678
USD 0.01 ordinary shares	Purchase	1847	21.679
USD 0.01 ordinary shares	Purchase	99	21.679
USD 0.01 ordinary shares	Purchase	83	21.68
USD 0.01 ordinary shares	Purchase	77922	21.68
USD 0.01 ordinary shares	Purchase	1246	21.68
USD 0.01 ordinary shares	Purchase	256	21.68
USD 0.01 ordinary shares	Purchase	292	21.68
USD 0.01 ordinary shares	Purchase	3006	21.681
USD 0.01 ordinary shares	Purchase	1410	21.681
USD 0.01 ordinary shares	Purchase	1496	21.681
USD 0.01 ordinary shares	Purchase	861	21.681
USD 0.01 ordinary shares	Purchase	35	21.681
USD 0.01 ordinary shares	Purchase	273	21.681
USD 0.01 ordinary shares	Purchase	190	21.681
USD 0.01 ordinary shares	Purchase	252	21.682
USD 0.01 ordinary shares	Purchase	388	21.682
USD 0.01 ordinary shares	Purchase	3230	21.682
USD 0.01 ordinary shares	Purchase	1821	21.682
USD 0.01 ordinary shares	Purchase	2013	21.682
USD 0.01 ordinary shares	Purchase	3363	21.682
USD 0.01 ordinary shares	Purchase	1362	21.682
USD 0.01 ordinary shares	Purchase	512	21.682
USD 0.01 ordinary shares	Purchase	1349	21.682
USD 0.01 ordinary shares	Purchase	670	21.682
USD 0.01 ordinary shares	Purchase	1566	21.683
USD 0.01 ordinary shares	Purchase	327	21.683
USD 0.01 ordinary shares	Purchase	1273	21.683
USD 0.01 ordinary shares	Purchase	61	21.683
USD 0.01 ordinary shares	Purchase	197	21.683
USD 0.01 ordinary shares	Purchase	431	21.683
USD 0.01 ordinary shares	Purchase	164	21.684
USD 0.01 ordinary shares	Purchase	94	21.684
USD 0.01 ordinary shares	Purchase	654	21.684
USD 0.01 ordinary shares	Purchase	123	21.684
USD 0.01 ordinary shares	Purchase	40	21.684
USD 0.01 ordinary shares	Purchase	150	21.685
USD 0.01 ordinary shares	Purchase	387	21.685
USD 0.01 ordinary shares	Purchase	240	21.685
USD 0.01 ordinary shares	Purchase	84337	21.685
USD 0.01 ordinary shares	Purchase	1441	21.685
USD 0.01 ordinary shares	Purchase	2917	21.685
USD 0.01 ordinary shares	Purchase	354	21.686
USD 0.01 ordinary shares	Purchase	177	21.686
USD 0.01 ordinary shares	Purchase	63695	21.69
USD 0.01 ordinary shares	Purchase	125	21.69
USD 0.01 ordinary shares	Purchase	43	21.691
USD 0.01 ordinary shares	Purchase	43	21.691
USD 0.01 ordinary shares	Purchase	72	21.692
USD 0.01 ordinary shares	Purchase	89	21.692
USD 0.01 ordinary shares	Purchase	500	21.693
USD 0.01 ordinary shares	Purchase	88	21.693
USD 0.01 ordinary shares	Purchase	129	21.693
USD 0.01 ordinary shares	Purchase	43	21.693
USD 0.01 ordinary shares	Purchase	196	21.693
USD 0.01 ordinary shares	Purchase	32	21.694
USD 0.01 ordinary shares	Purchase	66	21.694
USD 0.01 ordinary shares	Purchase	188	21.694
USD 0.01 ordinary shares	Purchase	91	21.694
USD 0.01 ordinary shares	Purchase	129	21.694
USD 0.01 ordinary shares	Purchase	245	21.695
USD 0.01 ordinary shares	Purchase	70	21.695
USD 0.01 ordinary shares	Purchase	313	21.695
USD 0.01 ordinary shares	Purchase	55733	21.695
USD 0.01 ordinary shares	Purchase	116	21.695
USD 0.01 ordinary shares	Purchase	89	21.695
USD 0.01 ordinary shares	Purchase	197	21.696
USD 0.01 ordinary shares	Purchase	225	21.696
USD 0.01 ordinary shares	Purchase	85	21.696
USD 0.01 ordinary shares	Purchase	116	21.696
USD 0.01 ordinary shares	Purchase	384	21.696
USD 0.01 ordinary shares	Purchase	181	21.696
USD 0.01 ordinary shares	Purchase	48	21.697
USD 0.01 ordinary shares	Purchase	206	21.698
USD 0.01 ordinary shares	Purchase	190	21.698
USD 0.01 ordinary shares	Purchase	114	21.698
USD 0.01 ordinary shares	Purchase	151	21.698
USD 0.01 ordinary shares	Purchase	178	21.698
USD 0.01 ordinary shares	Purchase	284	21.698
USD 0.01 ordinary shares	Purchase	96	21.698
USD 0.01 ordinary shares	Purchase	261	21.699
USD 0.01 ordinary shares	Purchase	111	21.699
USD 0.01 ordinary shares	Purchase	91	21.699
USD 0.01 ordinary shares	Purchase	262	21.699
USD 0.01 ordinary shares	Purchase	98	21.7
USD 0.01 ordinary shares	Purchase	91756	21.7
USD 0.01 ordinary shares	Purchase	159	21.7
USD 0.01 ordinary shares	Purchase	175	21.7
USD 0.01 ordinary shares	Purchase	284	21.7
USD 0.01 ordinary shares	Purchase	93	21.7
USD 0.01 ordinary shares	Purchase	109	21.701
USD 0.01 ordinary shares	Purchase	169	21.701
USD 0.01 ordinary shares	Purchase	212	21.701
USD 0.01 ordinary shares	Purchase	100	21.701
USD 0.01 ordinary shares	Purchase	170	21.701
USD 0.01 ordinary shares	Purchase	217	21.702
USD 0.01 ordinary shares	Purchase	101	21.702
USD 0.01 ordinary shares	Purchase	351	21.702
USD 0.01 ordinary shares	Purchase	94	21.702
USD 0.01 ordinary shares	Purchase	155	21.702
USD 0.01 ordinary shares	Purchase	588	21.702
USD 0.01 ordinary shares	Purchase	603	21.702
USD 0.01 ordinary shares	Purchase	383	21.703
USD 0.01 ordinary shares	Purchase	643	21.703
USD 0.01 ordinary shares	Purchase	774	21.703
USD 0.01 ordinary shares	Purchase	270	21.703
USD 0.01 ordinary shares	Purchase	435	21.703
USD 0.01 ordinary shares	Purchase	298	21.703
USD 0.01 ordinary shares	Purchase	394	21.703
USD 0.01 ordinary shares	Purchase	308	21.703
USD 0.01 ordinary shares	Purchase	202	21.703
USD 0.01 ordinary shares	Purchase	438	21.704
USD 0.01 ordinary shares	Purchase	354	21.704
USD 0.01 ordinary shares	Purchase	57	21.704
USD 0.01 ordinary shares	Purchase	1095	21.704
USD 0.01 ordinary shares	Purchase	2184	21.704
USD 0.01 ordinary shares	Purchase	20112	21.705
USD 0.01 ordinary shares	Purchase	2800	21.709
USD 0.01 ordinary shares	Purchase	31969	21.71
USD 0.01 ordinary shares	Purchase	2300	21.715
USD 0.01 ordinary shares	Purchase	6553	21.72
USD 0.01 ordinary shares	Purchase	400	21.723
USD 0.01 ordinary shares	Purchase	2320	21.725
USD 0.01 ordinary shares	Purchase	4561	21.73
USD 0.01 ordinary shares	Purchase	7000	21.74
USD 0.01 ordinary shares	Purchase	5634	21.743
USD 0.01 ordinary shares	Purchase	2515	21.744
USD 0.01 ordinary shares	Purchase	264	21.744
USD 0.01 ordinary shares	Purchase	3108	21.745
USD 0.01 ordinary shares	Purchase	334	21.745
USD 0.01 ordinary shares	Purchase	324	21.745
USD 0.01 ordinary shares	Purchase	9600	21.749
USD 0.01 ordinary shares	Purchase	27532	21.75
USD 0.01 ordinary shares	Purchase	289	21.75
USD 0.01 ordinary shares	Purchase	259	21.75
USD 0.01 ordinary shares	Purchase	290	21.75
USD 0.01 ordinary shares	Purchase	363	21.751
USD 0.01 ordinary shares	Purchase	800	21.753
USD 0.01 ordinary shares	Purchase	72291	21.755
USD 0.01 ordinary shares	Purchase	866	21.76
USD 0.01 ordinary shares	Sale	24	21.64

Ap29

(b) Cash-settled derivative transactions

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 3)

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

Ap30

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

(c) Attachments

Is a Supplemental Form 8 attached?

Date of disclosure	11/02/2026
Contact name	Janice Falcao
Telephone number	00442070722969

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap31

NOTES ON FORM 8.3

1. See the definition of “connected fund manager” in Rule 2.2 of Part A of the Rules.

2. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

3. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules.

4. See the definition of “dealing” in Rule 2.1 of Part A of the Rules.

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

6. See Rule 2.5(d) of Part A of the Rules.

7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260212339194/en/

FTSE 100 Latest

Value10,431.91

Change29.47